NYSE:VAPO - Vapotherm Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $44.00
  • Forecasted Upside: 33.74 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$32.90
▲ +0.65 (2.02%)
1 month | 3 months | 12 months
Get New Vapotherm Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VAPO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VAPO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$44.00
▲ +33.74% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Vapotherm in the last 3 months. The average price target is $44.00, with a high forecast of $53.00 and a low forecast of $39.00. The average price target represents a 33.74% upside from the last price of $32.90.
Buy
The current consensus among 4 investment analysts is to buy stock in Vapotherm. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/18/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/15/2021Piper SandlerBoost Price TargetOverweight$36.00 ➝ $39.00Low
i
1/14/2021Canaccord GenuityReiterated RatingBuy$40.00High
i
12/17/2020Piper SandlerInitiated CoverageOverweight$36.00High
i
11/5/2020Canaccord GenuityBoost Price TargetBuy$40.00 ➝ $54.00Medium
i
8/5/2020Canaccord GenuityBoost Price TargetBuy$34.00 ➝ $54.00High
i
8/4/2020BTIG ResearchReiterated RatingBuy$53.00High
i
Rating by Marie Thibault at BTIG Research
7/13/2020BTIG ResearchBoost Price Target$32.00 ➝ $53.00High
i
Rating by Marie Thibault at BTIG Research
6/5/2020Canaccord GenuityBoost Price TargetBuy$30.00 ➝ $34.00High
i
5/26/2020BTIG ResearchReiterated RatingBuy$32.00High
i
Rating by Marie Thibault at BTIG Research
5/6/2020Canaccord GenuityBoost Price TargetBuy$20.00 ➝ $30.00High
i
5/5/2020BTIG ResearchReiterated RatingBuy$32.00High
i
4/14/2020Canaccord GenuityBoost Price TargetBuy$14.00 ➝ $20.00High
i
3/5/2020William BlairReiterated RatingOutperformMedium
i
Rating by M. Kaczor at William Blair
3/5/2020BTIG ResearchReiterated RatingBuy$23.00High
i
3/13/2019Canaccord GenuityBoost Price TargetBuy$22.00 ➝ $27.00High
i
12/10/2018William BlairReiterated RatingOutperformHigh
i
Rating by M. Kaczor at William Blair
12/10/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$26.00Medium
i
12/10/2018Canaccord GenuityInitiated CoverageBuy ➝ Buy$25.00High
i
12/10/2018BTIG ResearchInitiated CoverageBuyHigh
i
12/10/2018William BlairInitiated CoverageOutperform ➝ OutperformHigh
i
(Data available from 1/16/2016 forward)
Vapotherm logo
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.
Read More

Today's Range

Now: $32.90
$32.22
$34.26

50 Day Range

MA: $27.87
$25.10
$32.72

52 Week Range

Now: $32.90
$6.86
$54.42

Volume

467,059 shs

Average Volume

336,976 shs

Market Capitalization

$844.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vapotherm?

The following equities research analysts have issued research reports on Vapotherm in the last year: BTIG Research, Canaccord Genuity, Piper Sandler, William Blair, and Zacks Investment Research.

What is the current price target for Vapotherm?

3 Wall Street analysts have set twelve-month price targets for Vapotherm in the last year. Their average twelve-month price target is $44.00, suggesting a possible upside of 33.7%. BTIG Research has the highest price target set, predicting VAPO will reach $53.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $39.00 for Vapotherm in the next year.

What is the current consensus analyst rating for Vapotherm?

Vapotherm currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VAPO will outperform the market and that investors should add to their positions of Vapotherm.

What other companies compete with Vapotherm?

How do I contact Vapotherm's investor relations team?

Vapotherm's physical mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company's listed phone number is 603-658-0411 and its investor relations email address is ir@vtherm.com. The official website for Vapotherm is www.vapotherm.com.